Fertility After Intrauterine Tamponing Balloon: Where Are we
- Conditions
- Hemorrhage PostpartumFertility Disorders
- Registration Number
- NCT04133402
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
Today, few data are available on the patient's fertility following intrauterine tamponade balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB). Several studies have concluded that there are no fertility disorders after conservative surgical treatment or embolization. BTIU is an essential treatment in the management of PPH. The aim was to evaluate post-BTIU fertility and the appearance of gynecological symptoms.
This is a bicentric retrospective study (Valenciennes, Lille, France), between 2012 and 2017. The data will be collected by telephone interview on fertility and various gynecological functional symptoms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 59
- Vaginal birth
- Post partum haemorrhage
- Intrauterine tamponing balloon
- Between 2012 and 2017
- CHRU Lille and CH Valenciennes
- Minor patients
- Initial intake started in another center (postpartum transfer).
- Refusal to participate in the study
- Invasive treatments for postpartum haemorrhage
- Caesarean
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of infertility 7 years defined as the absence of pregnancy after 12 months of attempted pregnancy.
- Secondary Outcome Measures
Name Time Method Type of gynecological complications after use of an intrauterine tamponade balloon. 7 years type = infections , pelvic pain, cycle disorders
type of obstetrical complications 7 years complications = intrauterine growth retardation, threat of premature labor
the frequency of obstetric complications for the next pregnancy 7 years Time to obtain a new pregnancy evaluating the stop of contraceptionand desire for pregnancy 7 years Frequency of gynecological complications after use of an intrauterine tamponade balloon. 7 years Frequency of recurrent postpartum haemorrhage in the next pregnancy 7 years
Trial Locations
- Locations (1)
Hôpital Roger Salengro, CHU
🇫🇷Lille, France